Arrowhead Pharmaceuticals, Inc.(NASDAQ : ARWR)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.15%||68.47||1.0%||$518.79m|
|REGN||Regeneron Pharmaceuticals, Inc.||-2.05%||608.76||2.7%||$416.43m|
|VRTX||Vertex Pharmaceuticals, Inc.||-2.14%||224.78||1.9%||$352.63m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-2.56%||2.66||0.7%||$185.94m|
|EXAS||EXACT Sciences Corp.||-6.42%||69.87||17.9%||$168.64m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.59%||89.42||13.7%||$135.66m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-3.80%||131.34||8.2%||$124.32m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.97%||84.52||4.2%||$108.78m|
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.